Lancaster Capital’s Angel Investment could help save eyesight of millions

Last week Lancaster Capital grabbed some attention online on BCC Scotland and in The Scotsman and Scotland on Sunday for their £400,000 investment to help develop a portable eye-scanning camera that could prevent blindness in millions of diabetes sufferers.

The handheld device, built by Rosyth-based company Epipole, is the first portable and affordable camera capable of diagnosing diabetic retinopathy – a condition responsible for two million cases of preventable blindness worldwide. Dr Craig Robertson, 45, the managing director and founder of Epipole, has signed a £400,000 investment deal which will enable his firm to develop a single working prototype into a commercial reality. 

As well as being a landmark for Epipole, it is also the first major deal for newly launched Scottish angel syndicate, Lancaster Capital.

Full and detailed information on the Lancaster Capital investment can be found in the original press release.

The coverage was acquired as a part of our ongoing campaign for Lancaster Capital. For information about The Holyrood Partnership and our services please contact a member of our team today.